4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-18-000020
Director sold 37,754 shares at $26.76 ($1,010,123)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-01-02 | Sale : show line 1 in the form | −37,754 | $26.76 | $1,010,123 | 1,913,605 | I |
| Open-market sales · 37,754 sh · avg $26.76 · $1,010,123 | ||||||
Loading xslF345X03/crisprfm4_jan22018.xml…